Biomerica, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BMRA | TRIB | ALBIO.PA | AIDX | INBS | RPID | |
|---|---|---|---|---|---|---|
| Market cap | 7.98M | 5.23M | 15.48M | 2.92M | 5.80M | 34.18M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 4.4 | -6.2 | 1.8 | — | 5.0 | -1.0 |
| Price/book | 2.2 | -0.1 | 0.4 | 1.7 | 0.9 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −31.76% | −77.67% | +56.67% | −99.04% | −77.59% | −75.24% |
| Today | +2.06% | −2.02% | +2.44% | −2.55% | −1.13% | −1.53% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All BMRA news ›Biomerica (NASDAQ:BMRA) Issues Earnings Results, Beats Expectations By $0.83 EPS
Posted by Sarita Garza on Oct 23rd, 2026 Biomerica stock opened at $1.69 on Friday. Biomerica has a one year low of $1.45 and a one year high of $3.09. The stock’s 50 day moving average is $2.06 and its 200 day moving average is $2.00.…
Contrasting Biomerica (NASDAQ:BMRA) and Envoy Medical (NASDAQ:COCH)
Posted by Kim Johansen on Oct 19th, 2026 Biomerica (NASDAQ:BMRA – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two…
Biomerica, Inc. Posts $1.23 Million Fiscal First-Quarter Loss as Sales Fall 8%
TOKENPOST Net sales totaled $1.265 million for the quarter ended Aug. 31. Cash and cash equivalents rose to $2.733 million from $1.308 million at May 31. Biomerica, Inc. recorded a $1.232 million net loss in its fiscal fi
Biomerica Reports First Quarter Fiscal 2027 Financial Results
Lower operating expenses did not offset the decline in gross profit, while an August share placement supported quarter-end liquidity. The MSA’s fee target above one million seven hundred fifty thousand dollars depends on additional work…
[EFFECT] BIOMERICA INC SEC Filing
Biomerica, Inc. (NASDAQ: BMRA) develops, manufactures and markets advanced diagnostic-guided IBS tests, rapid screening kits and CDMO services worldwide. [EFFECT] BIOMERICA INC SEC Filing Sentiment and the balance of points Rhea-AI…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- themarketsdaily.com3
- tokenpost.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.